Enzon Pharmaceuticals, Inc. (ENZN)

0.068 0.00 (0.00%) USD  |  OTCM  |  Feb 06, 16:00
More

Enzon Pharmaceuticals SG&A Expense (TTM) : 1.87M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ENZN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Agenus, Inc. 63.03M
Curis, Inc. 14.52M
LadRx Corp. 2.734M
Plus Therapeutics, Inc. 11.09M
Windtree Therapeutics, Inc. 7.706M